Loading
Kuo-Hsiang Chuang

Kuo-Hsiang Chuang

Chief Executive Officer, CytoArm Co.,Ltd.
Dr. Chuang is the CEO/founder of CytoArm Co., Ltd. and is a professor at Taipei Medical University, Taiwan. Dr. Chuang is a senior scientist with >20 years of experience in drug R&D and international IP layout, specializing in recombinant protein drug technology, tumor immunology, immune cell therapy, and autoimmune diseases. Dr. Chuang has published >50 SCI research papers, including a number of top international journals (Biomaterials, Journal of Controlled Release, Journal of Advanced Research; impact factor > 10). He also applied for >20 international invention patents and licensed 2 technologies to biotech companies. The next-generation T cell technology platform (Armed-T) created by Dr. Chuang's team has been licensed exclusively to CytoArm Co., Ltd. in 2020. The first Armed-T cell product is ready to initiate an investigator-initiated clinical trial in end-stage untreatable colorectal cancer. Dr. Chuang's achievements in the pharmacy field won the honor of the Ta-You Wu Memorial Award from Taiwan's Ministry of Science and Technology in 2021.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS